SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech binary events
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (7)4/3/2003 12:29:23 PM
From: scaram(o)uche  Read Replies (1) of 295
 
>> There's also this, but I don't know much about Xolair or its impact on DNA <<

The play would be Tanox. I only see April calls and puts, almost no open interest in the puts.

Genentech's Regulatory group is right up there with Amgen's. Xolair is of marginal benefit, but I'd be surprised if the margin hadn't been firmly established.

Don't follow the project.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News